Glooko, a digital health company based in Palo Alto, California, has secured $100 million in Series F funding.
Georgian led the investment round with participation from Health Catalyst Capital, Canaan, and other investors.
Glooko plans to use the latest funding to boost the global expansion of its digital healthcare platform. The platform is designed to help people with chronic conditions, particularly diabetes, by offering personalized care and better engagement with healthcare providers.
According to the official press statement, the funding also supports Glooko’s life sciences initiatives, enabling further development of its technology that integrates patient data for more efficient treatment and monitoring.
As of today, Glooko serves more than 4.4 million diabetes people worldwide.